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Conclusions. The provision of additional dietary hydroxy-Calcium oxalate stone formation in genetic hypercalciuric stone-
proline to GHS rats increases urinary oxalate excretion, cal-forming rats.
cium oxalate supersaturation and the ratio of calcium oxalate-Background. Over 54 generations, we have successfully bred
to-calcium phosphate supersaturation, resulting in the forma-a strain of rats that maximizes urinary calcium excretion. The
tion of calcium oxalate kidney stones. Thus, with the additionrats now consistently excrete 8 to 10 times as much calcium as
of a common amino acid, the GHS rats now not only modelcontrols, uniformly form poorly crystalline calcium phosphate
the most common metabolic abnormality found in patientskidney stones, and are termed genetic hypercalciuric stone-
with nephrolithiasis, hypercalciuria, but form the most commonforming (GHS) rats. These rats were used to test the hypothesis
type of kidney stone, calcium oxalate.that increasing urinary oxalate excretion would not only in-
crease the supersaturation with respect to the calcium oxalate
solid phase, but also would increase the ratio of calcium oxa-
late-to-calcium phosphate supersaturation and result in cal- Hypercalciuria is the most common metabolic abnor-cium oxalate stone formation.
mality in patients with nephrolithiasis [1–6]. Hypercalci-Methods. To increase urine oxalate excretion an oxalate pre-
uria raises urine supersaturation with respect to the solidcursor, hydroxyproline, was added to the diet of male GHS rats.
The GHS rats were fed a standard 1.2% calcium diet alone or phases of calcium oxalate and calcium phosphate en-
with 1%, 3% or 5% trans-4-hydroxy-l-proline (hydroxyproline). hancing the probability of nucleation and growth of crys-
Results. The addition of 1% hydroxyproline to the diet of tals into clinically significant stones [2]. Reversal of theGHS rats led to an increase in urinary oxalate excretion, which
hypercalciuria with thiazide diuretics, resulting in low-did not increase further with the provision of additional hy-
ering of supersaturation, has been shown to reduce clini-droxyproline. The addition of 1% and 3% hydroxyproline did
not alter calcium excretion while the provision of 5% hydroxy- cal stone formation in two long-term studies [7, 8].
proline led to a decrease in urine calcium excretion. The addi- To establish an animal model of hypercalciuria, we
tion of 1% hydroxyproline led to an increase in urinary calcium have successively inbred 54 generations of the most hyp-
oxalate supersaturation, which did not further increase with
ercalciuric progeny of hypercalciuric Sprague-Dawleyadditional hydroxyproline. The addition of 1% and 3% hy-
rats, each of which now excretes excessive amounts ofdroxyproline did not alter urinary supersaturation with respect
urinary calcium [9–23]. After eating standard rat chowto calcium hydrogen phosphate while the addition of 5% hy-
droxyproline tended to lower this supersaturation. Compared (1.2% Ca) for 18 weeks virtually all of these rats formed
to rats fed the control and the 3% hydroxyproline diet the renal stones, while there was no evidence of stone forma-
addition of 5% hydroxyproline increased the ratio of calcium tion in controls [19]. Because of their hypercalciuria andoxalate supersaturation to calcium phosphate supersaturation.
stone formation, we have termed these rats genetic hyp-Virtually all rats formed stones. In the control and 1% hydroxy-
ercalciuric stone-forming (GHS) rats [9, 12, 17, 19].proline group, all of the stones were composed of calcium and
phosphate (apatite), in the 3% hydroxyproline group the stones Our previous studies showed that the stones formed
were a mixture of apatite and calcium oxalate, while in the 5% by the GHS rats contained only calcium and phosphate,
hydroxyproline group all of the stones were calcium oxalate. without oxalate, and by x-ray diffraction were exclusively
poorly crystalline apatite [10, 13, 15, 19]. Experimental
reduction of urinary phosphorus and consequent calciumKey words: nephrolithiasis, hypercalciuria, hydroxyproline, kidney
stones. phosphate supersaturation eliminated the calcium phos-
phate stone formation in the GHS rats, demonstratingReceived for publication May 16, 2001
that the level of supersaturation had a substantial roleand in revised form August 31, 2001
Accepted for publication October 1, 2001 in regulating stone formation [13]. However, when fed
a normal calcium diet, the urine of GHS rats has a some- 2002 by the International Society of Nephrology
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what greater supersaturation with respect to calcium oxa- the next generation. A similar protocol was used for
screening and inbreeding of subsequent generations aslate than calcium phosphate, yet the rats form only cal-
cium phosphate stones. We have previously shown that described previously [9–23].
increasing dietary calcium led to an increase in the upper
Study protocollimit of metastability with increasing supersaturation
with respect to the calcium oxalate, but not to the calcium Thirty-one 54th generation male GHS rats, initially
weighing on average 135 grams, were placed in metabolicphosphate, solid phase, which would retard formation
of the calcium oxalate stones and favor formation of cages for 18 weeks. Each rat was initially provided with
13 g/day of food, an amount that we have previouslycalcium phosphate stones [15]. We hypothesized that
increasing urinary oxalate excretion resulting in an in- shown is completely consumed by a rat of this size [32].
At 12 weeks, the amount of food was increased to 15crease in the supersaturation with respect to the calcium
oxalate solid phase and an increase in the ratio of calcium g/day to account for the increased dietary needs of the
now larger rats.oxalate-to-calcium phosphate supersaturation would re-
sult in calcium oxalate stone formation, the most com- The male GHS rats were randomly divided into four
groups. Some GHS rats were fed a standard 1.2% cal-mon kidney stones formed in humans. Previously, in an
effort to increase calcium oxalate supersaturation, we cium, 0.65% phosphorus diet without modification, as
the control, while other rats were fed the same diet supple-added sodium oxalate to the diet of the GHS rats only to
find that the additional dietary oxalate bound substantial mented with 1%, 3% or 5% trans-4-hydroxy-l-proline
(hydroxyproline; Sigma, St. Louis, MO, USA). Male rats,amounts of dietary calcium, resulting in little change in
calcium oxalate supersaturation and no change in the as opposed to the female rats that were used in a number
of previous studies [9–11, 13, 15, 16, 19], were used in thetype of stones formed [9].
We then reasoned that the dietary provision of an current study because of their greater baseline oxalate
excretion when fed this standard calcium diet [20]. Ouroxalate precursor would not bind substantial intestinal
calcium but would produce an increase in urinary oxa- goal was to progressively increase the amount of the
dietary oxalate precursor (hydroxyproline) leading tolate. We wished to avoid the commonly used oxalate
precursor ethylene glycol [24–27], as it results in severe an increase in metabolic oxalate production [31]. Since
oxalate is an end product of metabolism [31], hydroxy-metabolic acidosis in mammals [28] and may, itself, be
nephrotoxic [29, 30]. Instead, GHS rats were fed addi- proline administration would be expected to, and has
been previously shown to, increase urinary oxalate excre-tional hydroxyproline, a common amino acid that is
metabolized to oxalate [31], to test the hypothesis that tion [33, 34]. An increase in urinary oxalate in the ab-
sence of other changes in urinary ion excretion wouldincreasing urinary oxalate excretion would not only in-
crease the supersaturation with respect to the calcium increase calcium oxalate supersaturation, the ratio of
calcium oxalate-to-calcium phosphate and, if our hypoth-oxalate solid phase, but would also increase the ratio
of calcium oxalate-to-calcium phosphate supersaturation esis is correct, predispose to calcium oxalate stone forma-
tion. The control group consisted of seven GHS ratsresulting in calcium oxalate stone formation. We found
that an increase in dietary hydroxyproline increased uri- and the three hydroxyproline-supplemented diet groups
consisted of eight GHS rats each. Every two weeks, twonary oxalate excretion, supersaturation with respect to
the calcium oxalate solid phase, the ratio of calcium successive 24-hour urine collections were obtained. The
first 24-hour urine samples were collected in thymol andoxalate-to-calcium phosphate supersaturation, and led
to the formation of kidney stones containing calcium were used for all measurements except oxalate. The sec-
ond 24-hour urine samples were collected in concen-oxalate. To our knowledge this is the first demonstration
of calcium oxalate stone formation, the most common trated HCl for measurement of oxalate. Both samples
were refrigerated at 4C until shipment. All biochemicalstone formed in humans, in an inbred rat model of hyper-
calciuria, the most common metabolic abnormality in measurements were completed within two weeks.
At the conclusion of the experiment (18 weeks), eachpatients who form kidney stones.
rat was killed. The kidneys, ureters, and bladder were
dissected en block and radiographic analysis was per-
METHODS
formed on six of the rats in each group. All stones identi-
Establishment of hypercalciuric rats fied by radiographic analysis were removed and ana-
lyzed. The kidneys of the remaining rats in each groupAdult Sprague-Dawley rats (Charles River Labora-
tories, Kingston, NY, USA) were screened for hypercal- were rapidly removed; one kidney was frozen on dry ice
and the other preserved in 10% Formalin for microscopicciuria by placing the rats in individual metabolic cages,
feeding them a constant amount of a standard calcium analysis. Any rat that ate less than 12 g of food per day
until week 12, or ate less then 14 g of food per day fromdiet, and measuring urine calcium excretion. The most
hypercalciuric male and female rats were used to breed week 12 until the conclusion of the study, or drank less
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than 15 mL of water on any day was excluded from 6.16  106 mol/L/L. The value of brushite in a solution
at equilibrium with a solid phase of brushite, the solubil-the remainder of the study; however, all rats met these
prospective criteria throughout the study. ity of brushite, is 3.981  107 mol/L/L. The value of
uric acid in a solution at equilibrium with a solid phase
Chemical determinations of uric acid, the solubility of uric acid, is 2.61 104 mol/
L/L per liter. The relative supersaturation for calciumCalcium was measured by reaction with arsenazo III
and then determined photometrically at 650 nm [35]. oxalate is calculated as the ratio of the free-ion activity
product of calcium and oxalate in the individual urineCreatinine was determined by a modification of the Jaffe
method by formation of a creatinine-picrate complex to the solubility of calcium oxalate. The relative supersat-
uration for brushite is calculated as the ratio of the free-[36]. Inorganic phosphorus was measured by reaction
with ammonium molybdate to form a colored phospho- ion activity product of calcium and phosphate in the
individual urine to the solubility of calcium phosphate.molybdate complex [37]. Uric acid was measured after
oxidation by uricase to produce allantoin and hydrogen The relative supersaturation for uric acid is calculated
as the ratio of the free-ion activity product of monohy-peroxide [38]. Magnesium was determined by combina-
tion with calmagite [39]. Ammonia was determined by a drogen urate and hydrogen in the individual urine to the
solubility of uric acid. Ratios of 1 connote a sample atcoupled enzyme system using glutamate dehydrogenase
and NADPH [40]. Sodium was determined by a selective equilibrium, above 1 supersaturation, and below 1 under-
saturation.electrode [41] and potassium using a valinomycin mem-
brane attached to a potassium electrode [42]. Chloride The ability of this computer program to accurately
predict the saturation of urine or other solution withwas measured by colorimetry using a silver/silver chlo-
ride electrode [43]. Oxalic acid was measured utilizing respect to the solid phase is excellent [9, 11, 13, 20, 21,
47, 50, 51]. With a series of 20 artificial solutions theoxalate oxidase, which oxidizes oxalate to hydrogen per-
oxide and carbon dioxide. The hydrogen peroxide then equilibrium calcium concentration and the extent of cal-
cium precipitation were predicted with average errorsreacts with 3-methyl-2-benzothiazolinone hydrozone and
3-(dimethyl)benzoic acid to form an indamine dye that of 5  9% and 5  8% (mean  SD), respectively [47].
We have used this computer program previously andwas monitored photometrically [44]. Citric acid was de-
termined using citrate lyase that catalyzed the conversion found excellent correspondence between calculated and
experimentally measured saturation in urine and bloodof citrate to oxaloacetic acid, which is then converted to
malic acid in the presence of malate dehydrogenase. The [9–11, 13, 15, 19–21] and in bone culture medium [50–52].
malic acid oxidized NADH to NAD that was monitored
X-ray diffractionphotometrically [45]. pH was measured by an ion selec-
tive electrode. Sulfate was measured by turbidity after The stones were finely powdered and put in a glass
capillary to be examined in an x-ray diffraction Debye-barium precipitation [46].
Sherrer powder camera using Cu K radiation (1.5418
Urinary supersaturation angstroms) with an exposure time of four hours at 40 kV
and 25 milliamperes. The recorded diffraction patternsThe calcium oxalate ion activity product was calcu-
lated using the computer program EQUIL developed by were compared to standard hydroxyapatite and calcium
oxalate patterns.Finlayson and associates [47–49]. The computer program
calculates free ion concentrations using the concentra-
Scanning electron microscopytions of measured ligands and known stability constants.
Ion activity coefficients are calculated from ionic strength Pieces of the stones were attached to aluminum stubs
with two-sided tape, sputter coated with gold and viewedusing the Davies modification of the Debye-Huckel solu-
tion to the Poisson-Boltzman equation. The program in a JEOL 820 electron microscope (JEOL, Tokyo, Ja-
pan) at 5 kV.simultaneously solves for all known binding interactions
among the measured substances. Oxalate, phosphorus,
Histological analysiscalcium and urate ion activities were used to calculate
the free-ion activity products. The free ions in solution The process of fixation and routine paraffin embedment
is known to dissolve calcium deposits in kidney tissue.are considered to be in an equilibrium with the dissolved
calcium oxalate governed by a stability constant (K) of Thus, one kidney from each rat was frozen in powered
dry ice to preserve the location of all crystalline deposits2.746 103 (mol/L)1, with the dissolved calcium hydro-
gen phosphate (brushite) governed by a K of 0.685  within the parenchyma and/or pelvis of the kidney. The
entire kidney was embedded in OCT compound (Miles103 (mol/L)1 and with the dissolved uric acid governed
by a K of 294  103 (mol/L)1. The value of calcium Laboratories, Elkhart, IN, USA) and 7 m sections were
cut in the mid-transverse plane on a Reichert-Jung cryo-oxalate in a solution at equilibrium with a solid phase
of calcium oxalate, the solubility of calcium oxalate, is stat. Sections were picked up on charged slides and kept
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frozen until fixed in acetone for 15 to 20 seconds. The
even numbered slides were dehydrated in one change
of 100% ethanol, followed by two changes of Hemo-De
clearing agent (Fisher Scientific, Pittsburgh, PA, USA)
before cover slipping the unstained sections. These sec-
tions were viewed by polarizing optics using a Leica
DMR microscope to detect the birefringent calcium crys-
tals. Images were acquired with a Polaroid DMC digital
camera (resolution set at 1600  1200 pixels). All odd-
numbered slides were stained with 1% toluidine blue,
dehydrated in a series of graded ethanols, rinsed in
Hemo-De, and then cover slipped in order to determine
the location of the crystalline deposits within the kidney.
Those kidneys fixed in 10% buffered formalin were rou-
tinely processed for embedment in paraffin in order to
assess the kidney for tubular and/or interstitial pathol-
ogy. Sites of crystal location were then correlated with
regions of renal injury. Sections were cut at 4 to 6 m
and stained for calcium deposits using the Yasue method
[53], which uses 5% aqueous silver nitrate and rubeanic
acid to generate a dark brown to black histochemical
staining of calcium deposits. All sections were counter-
stained with Safranin O, which allowed accurate identi-
fication of all tubular segments.
Statistical analysis
All values are expressed as mean  SE. Tests of sig-
nificance were calculated by analysis of variance with the
Bonferroni correction for multiple comparisons using
conventional computer programs (BMDP; University of
California, Los Angeles, CA, USA). P 0.05 was consid-
ered significant.
RESULTS
Urine ion excretion, volume and pH
Fig. 1. Urine oxalate and calcium excretion and volume (mean  SE)Every two weeks, two successive 24-hour urine collec-
in genetic hypercalciuric stone forming (GHS) rats fed either a control
tions were obtained. The individual urine collections for diet without modification or the diet supplemented with 1%, 3% or 5%
hydroxyproline for a total of 18 weeks. Every two weeks, two successivethe 31 rats divided into four groups were analyzed sepa-
24-hour urine collections were obtained. The individual urine collectionsrately and were then averaged over the first six weeks
for the 31 rats divided into the four groups were analyzed separately
(weeks 1 to 6), the second six weeks (weeks 7 to 12), and were then averaged over the first six weeks (weeks 1–6), the second
six weeks (weeks 7–12), and the final six weeks (weeks 13–18). Abbrevia-and the final six weeks (weeks 13 to 18).
tions are: Control, GHS rats fed a 1.2% calcium, 0.65% phosphorusWith respect to urine oxalate, during weeks 1 to 6 and
diet without modification (N  7); 1%, GHS rats fed the control diet
7 to 12 there was an increase in urine oxalate excretion supplemented with 1% hydroxyproline (N  8); 3%, GHS rats fed the
control diet supplemented with 3% hydroxyproline (N  8); 5%, GHSin GHS rats eating the 1%, 3% and 5% hydroxyproline
rats fed the control diet supplemented with 5% hydroxyproline (N  8).supplemented diet compared to rats eating the control
*Different from control, same time period, P  0.05; different from
diet (Fig. 1A). There was no difference in oxalate excre- 1% hydroxyproline, same time period, P  0.05; odifferent from 3%
hydroxyproline, same time period, P  0.05.tion between rats eating 1%, 3% and 5% hydroxyproline
during these two time periods. During weeks 13 to 18
there was an increase in urine oxalate excretion in GHS
rats eating 1% and 5% hydroxyproline, but not in rats
of 1% hydroxyproline to the diet of GHS rats led toeating the 3% hydroxyproline compared to rats eating
an increase in urinary oxalate excretion, which did notthe control diet. There was no difference in oxalate ex-
further increase with the provision of additional hydroxy-cretion between rats eating 1% and 5% hydroxyproline
during this time period. Thus, in general, the addition proline.
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With respect to urine calcium, during all three time
periods there was no change in urine calcium excretion
in GHS rats eating the 1% and 3% hydroxyproline sup-
plemented diet compared to rats eating the control diet
(Fig. 1B). During all three time periods there was a
decrease in urine calcium excretion in rats eating the
5% hydroxyproline supplemented diet compared to rats
eating the control, 1% and 3% hydroxyproline supple-
mented diet. Thus, the addition of 1% and 3% hydroxy-
proline did not alter calcium excretion, while the provi-
sion of 5% hydroxyproline led to a decrease in urine
calcium excretion.
With respect to urine volume, during the first time
period there was a reduction in urine volume in GHS
rats eating the 3% hydroxyproline supplemented diet
compared to rats eating the 1% hydroxyproline supple-
mented diet (Fig. 1C). During the second time period
there was a decrease in urine volume in each of the
groups eating the hydroxyproline-supplemented diets
compared to rats eating the control diet. During the third
time period there was no difference in urine volume in
any of the four groups of rats. Thus, the addition of
hydroxyproline did not consistently alter urine volume.
With respect to urine pH, during the first time period
there was an increase in urine pH in GHS rats fed the
hydroxyproline supplemented diets compared to rats
eating the control diet (Fig. 2A). During the second and
third time periods there was no difference in the urine
pH in any of the four groups of rats. Thus, the addition
of hydroxyproline did not consistently alter urine pH.
With respect to urine citrate, during the first time
period there was no difference in urine citrate in any of
the four groups of rats (Fig. 2B). During the second time
period there was an increase in urine citrate in rats fed
the 1% hydroxyproline supplemented diet compared to
those fed the control diet, a decrease in the rats fed the
3% and 5% hydroxyproline supplemented diet com- Fig. 2. Urine pH, magnesium and citrate excretion (mean  SE) in
pared to the 1% hydroxyproline supplemented diet, and genetic hypercalciuric stone-forming (GHS) rats fed either a control
diet without modification or the diet supplemented with 1%, 3% ora decrease in the 5% hydroxyproline supplemented diet
5% hydroxyproline for a total of 18 weeks. Methods and abbreviationscompared to the 3% hydroxyproline supplemented diet. are in the legend to Figure 1.
During the third time period there was a decrease in
urine citrate in the rats fed the 5% hydroxyproline sup-
plemented diet compared to all of the other groups of
rats. Thus, the addition of hydroxyproline did not consis- magnesium in rats eating the 5% hydroxyproline supple-
tently alter urine citrate excretion. mented diet compared to the rats eating the 1% hydroxy-
With respect to urine magnesium, during the first time proline supplemented diet. Thus, the addition of hy-
period there was a reduction in urine magnesium in GHS droxyproline did not consistently alter urine magnesium
rats eating the 5% hydroxyproline supplemented diet excretion.
compared to rats eating each of the other diets (Fig. 2C).
During the second time period there was an increase in
Urinary supersaturationurine magnesium in the rats eating the 1% hydroxypro-
With respect to urine calcium oxalate supersaturation,line diet compared to rats eating the control diet and
during all three time periods there was an increase ina reduction in rats eating the 5% hydroxyproline diet
calcium oxalate supersaturation in GHS rats eating thecompared to the 1% and 3% hydroxyproline diets. Dur-
ing the third time period there was a reduction in urine 1%, 3% and 5% hydroxyproline supplemented diet com-
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Fig. 4. Number of kidneys with stones ( ) and number of rats that
formed stones (). GHS rats fed either a control diet without modifica-
tion or the diet supplemented with 1%, 3% or 5% hydroxyproline for
a total of 18 weeks. Dashed line represents the maximum number of
kidneys or rats with stones. Abbreviations are in Figure 1 legend.
tended to lower calcium hydrogen phosphate supersatu-
ration.
Stone formation
All GHS rats fed the control diet, the 1% hydroxypro-
line diet and the 5% hydroxyproline supplemented diet
formed kidney stones, and 5 of 6 rats fed the 3% hydroxy-
Fig. 3. Relative saturation ratio of calcium oxalate (CaOx) and calcium
proline supplemented diet formed kidney stones (Fig.hydrogen phosphate (CaHPO4) in GHS rats fed either a control diet
without modification or the diet supplemented with 1%, 3% or 5% 4). Stones were found to be calcium phosphate (apatite)
hydroxyproline for a total of 18 weeks. Methods and abbreviations are alone, calcium oxalate dihydrate and calcium oxalate
in the legend to Figure 1.
monohydrate mixed with apatite, and calcium oxalate
dihydrate and calcium oxalate dihydrate (Fig. 5).
In the control and in the 1% hydroxyproline supple-
mented group all of the stones were apatite; in the 3%pared to rats eating the control diet (Fig. 3A). There
hydroxyproline supplemented group the stones were awas no difference in calcium oxalate supersaturation be-
mixture of calcium oxalate dihydrate, calcium oxalatetween rats eating 1%, 3% and 5% hydroxyproline sup-
monohydrate and apatite. In the 5% hydroxyproline sup-plemented diet during these three time periods. Thus,
plemented group all stones were calcium oxalate dihy-the addition of 1% hydroxyproline to the diet of GHS
drate and calcium oxalate monohydrate (Fig. 6).rats led to an increase in urinary calcium oxalate super-
saturation that did not increase further with the provision
Histological analysisof additional hydroxyproline.
Both the frozen and fixed kidney sections clearlyWith respect to urine calcium hydrogen phosphate
showed the crystalline deposits to be located only all(CaHPO4, brushite) supersaturation, during weeks 1 to
along the length of the urinary space (Figs. 7 and 8), a6 there was a reduction of calcium hydrogen phosphate
supersaturation in GHS rats fed 5% hydroxyproline sup- region of the rat kidney that represents the proximal
end of the ureter and surrounds the single renal papilla.plemented diet compared to rats eating the control and
the 3% hydroxyproline supplemented diet (Fig. 3B). This location of the crystalline material was identical for
all four groups (Figs. 7 and 8). No crystalline depositsDuring weeks 7 to 12 there was no difference in calcium
hydrogen phosphate supersaturation in any of the four were found within tubular lumens of the cortex and me-
dulla, except for one example of a region of deposits ingroups of rats. During weeks 13 to 18 there was a reduc-
tion of calcium hydrogen phosphate supersaturation in the lumen of a Duct of Belini of an animal in the 5%
hydroxyproline group (not shown). Generally, the crys-GHS rats fed 5% hydroxyproline supplemented diet
compared to rats eating the control and the 1% and 3% talline material was found to be free within the urinary
space such that as this space was surgically opened, thehydroxyproline supplemented diet. Thus, the addition
of 1% and 3% hydroxyproline to the diet did not alter crystalline material flowed out of the space (inserts a,
Figs. 7 and 8). However, there were sites where theurinary supersaturation with respect to calcium hydrogen
phosphate, while the addition of 5% hydroxyproline crystalline material appeared wedged within the fornix
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Fig. 5. X-ray diffraction pattern of GHS rat
kidney stones. Patterns of (A) poorly crystal-
line hydroxyapatite from rats fed the control
diet, (B) a mixture of hydroxyapatite and cal-
cium oxalate monohydrate (COM) and cal-
cium oxalate dihydrate (COD) from rats fed
the 3% hydroxyproline supplemented diet,
and (C) a mixture of calcium oxalate monohy-
drate and calcium oxalate dihydrate from rats
fed the 5% hydroxyproline supplemented diet
are shown.
of the urinary space (insert b, Fig. 7) or attached to the crease in supersaturation with respect to calcium oxalate
surface of the urothelium lining both papilla and outer coupled with the decrease in supersaturation with re-
wall of this space (insert b, Fig. 8). spect to calcium hydrogen phosphate resulted in a sig-
nificant increase in the ratio of calcium oxalate to calcium
Ratio of calcium oxalate-to-calcium phosphate hydrogen phosphate, to the extent that the supersatura-
supersaturation compared to stone type tion of calcium oxalate was 2.5 times that of calcium
In the control group during all three time periods hydrogen phosphate. The stones were exclusively cal-
the supersaturation with respect to calcium oxalate was cium oxalate. Thus, at the lowest ratio of calcium oxalate-
similar to that with respect to calcium hydrogen phos- to-calcium hydrogen phosphate supersaturation there
phate (Fig. 9A), resulting in the ratio of calcium oxalate were only calcium phosphate stones, while in the mid
to calcium hydrogen phosphate supersaturation of just ratios the stones tended to be mixed, and at the highest
above unity (Fig. 9B); the stones were composed of only ratio the stones were exclusively calcium oxalate.
calcium and phosphate. In the 1% hydroxyproline group
there was an increase in calcium oxalate supersaturation
DISCUSSIONwithout a change in calcium hydrogen phosphate super-
The genetic hypercalciuric stone forming (GHS) ratssaturation, resulting in a significant increase in the ratio
are bred to maximize excretion of urinary calcium as aof calcium oxalate-to-calcium hydrogen phosphate. The
model of the most common known metabolic abnormal-stones remained composed only of calcium and phos-
ity in patients who form calcium containing kidney stonesphate. Compared to control, in the 3% hydroxyproline
[1–6]. The GHS rats have previously been shown togroup there was an increase in the supersaturation with
universally form kidney stones that contain only calciumrespect to calcium oxalate and no change with respect
bound to phosphate and not to oxalate [10, 13, 15, 19].to calcium hydrogen phosphate, resulting in a significant
In this study, the GHS rats were fed additional hydroxy-increase in the ratio of the supersaturations. The stones
now consisted of calcium bound to phosphate and bound proline, which led not only to an increase in oxalate
excretion and the supersaturation with respect to theto oxalate. Compared to both the control and 3% hy-
droxyproline groups, with 5% hydroxyproline the in- calcium oxalate solid phase, but to an increase in the ratio
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Fig. 6. Scanning electron micrographs of kid-
ney stones from GHS rats from the 5% hydroxy-
proline supplemented group showing calcium
oxalate crystals (A, B) resembling stones
found in humans. Note the large bipyramidal
crystals of calcium oxalate dihydrate.
of calcium oxalate-to-calcium phosphate supersaturation with respect to calcium oxalate exceeds the calcium oxa-
late supersaturation, decreasing the probability of stoneand to calcium oxalate stone formation, the most com-
mon type of stone formed by patients with nephrolithia- formation [15]. This elevated ULM may be due to the
presence of inhibitors of urinary crystallization such assis [1–6]. Thus, the GHS rats have the most common
metabolic abnormality in patients who form kidney nephrolcalcin, uropontin, and Tamm-Horsfall protein
[54]. We have not studied the inhibitor profile of thestones and now, with the addition of a dietary amino
acid, form the most common type of kidney stone found GHS rats nor determined if the type, amount or activity
of any inhibitor is altered with changes in urinary calciumin patients with nephrolithiasis.
The robust urinary supersaturation with respect to the or oxalate excretion. A physiologic system in which in-
hibitor quantity or activity is modulated by urinary ioncalcium oxalate solid phase observed in the GHS rats
fed the control diet, approximately four- to sevenfold, excretion or supersaturation would be protective against
the nucleation or aggregation of crystals that would re-is not sufficient to induce formation of calcium oxalate
kidney stones. We have previously shown that on this diet sult in clinical nephrolithiasis.
Comparison of the urinary supersaturations in the(1.2% calcium) the upper limit of metastability (ULM,
the minimal urinary concentration at which crystals form) GHS rats with respect to calcium oxalate and calcium
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Fig. 7. Mid-transverse paraffin section through
a kidney from the control group and stained
by the Yasue method, which uses 5% aqueous
silver nitrate and rubeanic acid to generate a
dark brown to black histochemical staining of
all calcium deposits. Note that the dark brown-
to-black stained crystalline material (arrows)
appears only in the urinary space, and no de-
posits are noted within the lumens of the renal
tubules. (Insert a) The amount and location
of the crystalline deposits (arrowheads) in the
urinary space immediately after the kidney
had been transected and viewed under a dis-
section microscope. Small, individual crystals
(asterisks) have floated from the urinary space
and into the fluid surrounding the cut margin
of the kidney. (Insert b) A high magnification
view of crystalline deposits that appear tightly
wedged within the fornix of the urinary space
(180; insert a 100; insert b 600).
Fig. 8. Mid-transverse paraffin section through
a kidney from the 5% hydroxyproline group
and stained by the Yasue method that uses
5% aqueous silver nitrate and rubeanic acid to
generate a dark brown to black histochemical
staining of all calcium deposits. Note that the
dark brown-to-black stained crystalline mate-
rial (arrows) appears only in the urinary space.
(Insert a) The amount and location of the crys-
talline deposits (arrowheads) in the urinary
space immediately after the kidney had been
transected and viewed under a dissection mi-
croscope. Similar to that shown in insert a of
Figure 7, small, individual crystals (asterisks)
have floated from the urinary space and into
the fluid surrounding the cut margin of the
kidney. (Insert b) A line of crystalline material
that appears attached to the urothelium
(180; insert a 100; insert b 900).
hydrogen phosphate produced by 1% and 3% hydroxy- may be due to subtle differences in supersaturation or
to differences in the influence of urinary oxalate on theproline dietary supplementation with the stone crystal
type is informative. With both 1% and 3% hydroxypro- ULM induced by the addition of hydroxyproline to the
diet. The influence of additional dietary hydroxyprolineline supplementation, the supersaturation with respect to
calcium oxalate increased and the supersaturation with to the ULM for calcium oxalate must be investigated in
a future study, as the results from the current study confirmrespect to calcium hydrogen phosphate was not altered,
yet with 1% the rats formed only calcium phosphate our previously stated hypothesis that stone formation is
not simply a function of increased supersaturation alone,(apatite) stones and with 3% the rats formed a combina-
tion of apatite and calcium oxalate stones. The reason but appears to involve differences in ULM [15].
Genetic hypercalciuric stone-forming rats fed the 5%for this difference in the crystal type is not clear, but
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Fig. 9. (A) Relative saturation ratio of calcium oxalate (CaOx) compared with relative supersaturation ratio of calcium hydrogen phosphate
(CaHPO4) in GHS rats fed either a control diet without modification () or the diet supplemented with 1% (), 3% () or 5% () hydroxyproline
for a total of 18 weeks. (B) Ratio of the relative saturation ratio of calcium oxalate (CaOx) to that of calcium hydrogen phosphate (CaHPO4) at
each dietary hydroxyproline concentration. Methods are defined in Figure 1 legend. Symbols are: (*) different from control, P  0.05; (o) different
from 3% hydroxyproline, P  0.05.
hydroxyproline supplemented diet formed only calcium the calcium oxalate stone-formers though still above
those of the rats in the 5% hydroxyproline group. Thus,oxalate stones. In this group, compared to rats fed the
1% and 3% hydroxyproline supplemented diet, there the calcium oxalate supersaturation values for the hu-
mans forming calcium oxalate stones overlap with thosewas no further increase in the supersaturation with re-
spect to calcium oxalate, but there was a general fall in rats fed the 5% hydroxyproline supplemented diet, while
the calcium phosphate supersaturation values for hu-the supersaturation with respect to calcium hydrogen
phosphate, resulting in an increase in the ratio of calcium mans forming calcium phosphate stones are not above
3, the low point in the rat figure (Fig. 9). Both humansoxalate to calcium hydrogen phosphate supersaturation
(Fig. 9). It is possible that the fall in supersaturation with and rats appear balanced with respect to their suscepti-
bility to calcium oxalate stones while humans appear farrespect to calcium hydrogen phosphate, or in the ratios
of supersaturations, was sufficient to prevent this type less able to withstand calcium phosphate supersaturation
compared to rats, as humans form calcium phosphateof stone from forming. This hypothesis is consistent with
our previous observation that lowering the supersatura- stones at calcium phosphate supersaturation levels below
3. Because of the higher tolerance of rats for calciumtion with respect to calcium phosphate stone formation
below 4 to 5, similar to that observed in the 5% hydroxy- phosphate stones, they do not form these stones until
their urinary supersaturation increases far above thatproline supplemented diet (Fig. 3B), led to elimination
of apatite stone formation in our rats [13]. observed in human calcium phosphate stone-formers,
while with respect to the calcium oxalate solid-phase,In human male calcium oxalate stone-formers, we
have found that the level of supersaturation with respect rats form stones at supersaturations similar to those ob-
served in human calcium oxalate stone-formers. In bothto calcium oxalate was 9.28 and the supersaturation with
respect to calcium phosphate was 1.62, resulting in a humans and GHS rats, calcium oxalate stones formed
at the higher supersaturation for calcium oxalate to su-ratio of 5.7 [55], which is considerably higher than that
observed in the rats fed 5% hydroxyproline (Fig. 9B). persaturation for calcium phosphate ratios and calcium
phosphate stones formed at the lower supersaturationAmong human male calcium phosphate stone-formers,
the level of supersaturation with respect to calcium oxa- ratios. Whether the absolute magnitude of an individual
supersaturation or the ratio of calcium oxalate-to-cal-late was 8.8 and with respect to calcium phosphate was
2.41, resulting in a ratio of 3.65, considerably lower than cium phosphate supersaturation will be more helpful
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in predicting the type of stone formed remains to be oxalate and calcium phosphate, thus paralleling human
stone formation. Feeding rats ethylene glycol resulteddetermined.
While the majority of human kidney stones are com- only in pure calcium oxalate stones [24, 25].
The principal mechanism for the excessive calciumposed of calcium oxalate, most stone formers do not
excrete increased amounts of urinary oxalate compared excretion in the GHS rats appears to be an increase in
intestinal calcium absorption [23]. The increased intesti-to the non-stone forming population [1–6]. Oxalate is
an end product of metabolism [31] and the majority of nal calcium absorption appears to be mediated not by
an increase in the serum level of 1,25(OH)2D3, but byurinary oxalate is derived from endogenous metabolism.
A recent study indicates that approximately 25 to 45% an increase in the number of intestinal vitamin D recep-
tors [22]. When the GHS rats are fed a very low calciumof excreted oxalate is derived from dietary oxalate inges-
diet, urine calcium excretion remains elevated comparedtion [56]. However, excess urinary oxalate is a known
to that of similarly treated control rats, indicating a defectrisk factor for calcium oxalate nephrolithiasis [2, 3] and
in renal calcium reabsorption and/or an increase in bonecan occur secondary to the genetic disorders of primary
resorption [21]. When exposed to increasing amountshyperoxaluria [57–59] or to enhanced intestinal oxalate
of 1,25(OH)2D3 the bone from these hypercalciuric ratsabsorption [2, 3]. Primary hyperoxaluria type 1 is due to a
releases more calcium compared to bone of control ratshepatic deficiency in the peroxisomal enzyme alanine:
[18], and inhibition of bone resorption with the bisphos-glyoxylate aminotransferase, while primary hyperoxal-
phonate alendronate substantially decreases the hyper-uria type 2 is due to a defect in d-glycerate dehydroge-
calciuria when these rats are fed a low calcium diet [11].nase/glyoxylate reductase [58]. Patients with gastrointes-
In addition, a primary defect in renal calcium reabsorp-tinal disorders such as celiac sprue or Crohn’s disease, or
tion is observed during carefully controlled clearancefollowing intestinal bypass surgery, absorb excess oxa-
studies [16]. We have shown that in addition to the intes-late.
tine, both the bone and kidney of the hypercalciuric ratsIncreasing dietary oxalate will lead to increased oxa-
have an increased number of vitamin D receptors [14,late absorption and excretion [9, 60–62]. When GHS
18, 22]. Thus, the GHS rats appear to have a systemicrats were fed additional sodium oxalate, urine oxalate
abnormality in calcium homeostasis; they absorb moreexcretion rose but urine calcium fell, presumably due to
intestinal calcium, they resorb more bone and they fail tobinding of intestinal calcium by the additional dietary
adequately reabsorb filtered calcium. Calcium transportoxalate, and the supersaturation with respect to calcium
abnormalities similar to those documented in the GHSoxalate actually fell [9]. In humans, additional dietary
rats have been observed in many patients with idiopathiccalcium has been shown to lower urinary oxalate, again
hypercalciuria and nephrolithiasis [2], and thus the GHSpresumably due to intestinal complexation between cal-
rats appear to be an excellent model in which to studycium and oxalate [63]. In the current study urinary oxa-
human nephrolithiasis.late excretion and calcium oxalate supersaturation were
We have shown that addition of the oxalate precursor,increased by augmenting the diet with an oxalate precur-
hydroxyproline, to the diet of GHS rats results in ansor and not oxalate itself.
increase in urine oxalate excretion, calcium oxalate su-It is unclear why urinary oxalate did not continue to
persaturation, the ratio of calcium oxalate-to-calciumincrease as the concentration of dietary hydroxyproline
phosphate supersaturation and in calcium oxalate stonewas increased. Perhaps the intestinal absorption of hy-
formation. The GHS rats model the most common meta-droxyproline is limited, or the metabolic conversion of
bolic abnormality found in patients with nephrolithiasis,hydroxyproline to oxalate is limited or, more likely, any
hypercalciuria, and now, with the addition of a commonadditional urinary oxalate was incorporated into calcium
amino acid to the diet, they form the most commonoxalate stones. Were additional urinary oxalate incorpo-
kidney stone found in humans, calcium oxalate.rated into calcium oxalate stones one would not necessar-
ily have expected to detect a fall in urinary calcium, as
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